ABCB1 and esophageal squamous cell carcinoma: Interestingly, we found that ASA could reduce the efflux activity of ESCC cells by inhibiting PI3K signalling, which was reported to mediate P-glycoprotein (P-gp) expression and enhance DDP resistance [52].